158 related articles for article (PubMed ID: 33284191)
1. Some Morphology Frontiers of Dysplasia in the Tubular Gastrointestinal Tract: The Rodger C. Haggitt Memorial Lecture.
Montgomery EA; Arnold CA; Lam-Himlin DM; McDonald OG; Poveda JC; Salimian KJ; Voltaggio L; Waters KM; Wood LD; Singhi AD
Am J Surg Pathol; 2022 Jan; 46(1):e1-e14. PubMed ID: 33284191
[TBL] [Abstract][Full Text] [Related]
2. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?
Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY
Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707
[TBL] [Abstract][Full Text] [Related]
3. Neoplasia without dysplasia: lessons from Barrett esophagus and other tubal gut neoplasms.
Odze RD; Maley CC
Arch Pathol Lab Med; 2010 Jun; 134(6):896-906. PubMed ID: 20524867
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of immunohistochemistry in pre-malignant lesions of the gastrointestinal tract.
Ma C; Pai RK
Semin Diagn Pathol; 2015 Sep; 32(5):334-43. PubMed ID: 25749205
[TBL] [Abstract][Full Text] [Related]
5. Foveolar type dysplasia in Barrett esophagus.
Brown IS; Whiteman DC; Lauwers GY
Mod Pathol; 2010 Jun; 23(6):834-43. PubMed ID: 20228780
[TBL] [Abstract][Full Text] [Related]
6. Dysplasia in the gastrointestinal tract.
Geboes K
Hepatogastroenterology; 1999; 46(26):657-60. PubMed ID: 10370592
[TBL] [Abstract][Full Text] [Related]
7. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
8. How to make a Barrett esophagus: pathophysiology of columnar metaplasia of the esophagus.
Guillem PG
Dig Dis Sci; 2005 Mar; 50(3):415-24. PubMed ID: 15810619
[TBL] [Abstract][Full Text] [Related]
9. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic differences between esophageal and gastric intestinal metaplasia.
Piazuelo MB; Haque S; Delgado A; Du JX; Rodriguez F; Correa P
Mod Pathol; 2004 Jan; 17(1):62-74. PubMed ID: 14631367
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical assessment of Survivin and Bcl3 expression as potential biomarkers for NF-κB activation in the Barrett metaplasia-dysplasia-adenocarcinoma sequence.
Puccio I; Khan S; Butt A; Graham D; Sehgal V; Patel D; Novelli M; Lovat LB; Rodriguez-Justo M; Hamoudi RA
Int J Exp Pathol; 2018 Feb; 99(1):10-14. PubMed ID: 29473241
[TBL] [Abstract][Full Text] [Related]
12. The pathology of epithelial pre-malignancy of the gastrointestinal tract.
Guindi M; Riddell RH
Best Pract Res Clin Gastroenterol; 2001 Apr; 15(2):191-210. PubMed ID: 11355911
[TBL] [Abstract][Full Text] [Related]
13. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
Asthana N; Mandich D; Ligato S
Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
[TBL] [Abstract][Full Text] [Related]
14. The Use of Ancillary Stains in the Diagnosis of Barrett Esophagus and Barrett Esophagus-associated Dysplasia: Recommendations From the Rodger C. Haggitt Gastrointestinal Pathology Society.
Srivastava A; Appelman H; Goldsmith JD; Davison JM; Hart J; Krasinskas AM
Am J Surg Pathol; 2017 May; 41(5):e8-e21. PubMed ID: 28248814
[TBL] [Abstract][Full Text] [Related]
15. The histologic squamo-oxyntic gap: an accurate and reproducible diagnostic marker of gastroesophageal reflux disease.
Chandrasoma P; Wijetunge S; Demeester SR; Hagen J; Demeester TR
Am J Surg Pathol; 2010 Nov; 34(11):1574-81. PubMed ID: 20871393
[TBL] [Abstract][Full Text] [Related]
16. Gastric foveolar metaplasia with dysplastic changes in Brunner gland hyperplasia: possible precursor lesions for Brunner gland adenocarcinoma.
Sakurai T; Sakashita H; Honjo G; Kasyu I; Manabe T
Am J Surg Pathol; 2005 Nov; 29(11):1442-8. PubMed ID: 16224210
[TBL] [Abstract][Full Text] [Related]
17. Epithelial metaplasia and the development of cancer.
Quinlan JM; Colleypriest BJ; Farrant M; Tosh D
Biochim Biophys Acta; 2007 Sep; 1776(1):10-21. PubMed ID: 17618050
[TBL] [Abstract][Full Text] [Related]
18. Expression and significance of Musashi-1 in gastric cancer and precancerous lesions.
Kuang RG; Kuang Y; Luo QF; Zhou CJ; Ji R; Wang JW
World J Gastroenterol; 2013 Oct; 19(39):6637-44. PubMed ID: 24151393
[TBL] [Abstract][Full Text] [Related]
19. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer.
Liu Q; Teh M; Ito K; Shah N; Ito Y; Yeoh KG
Mod Pathol; 2007 Dec; 20(12):1286-97. PubMed ID: 17906616
[TBL] [Abstract][Full Text] [Related]
20. [Barrett's esophagus: diagnosis and therapy].
Schmassmann A; Gebbers JO
Praxis (Bern 1994); 2005 May; 94(21):861-8. PubMed ID: 15966485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
